Subramaniam Kannan
Pfizer Upjohn, Sydney, New South Wales, Australia.
Stud Health Technol Inform. 2020 Jun 26;272:374-378. doi: 10.3233/SHTI200573.
Key noncommunicable diseases (NCD) such as cardiovascular disease, diabetes, cancer and chronic respiratory disease are responsible for 71% of all deaths worldwide. Many of these deaths are premature and impact low- and middle-income countries (LMIC) the most. The economic realities in LMICs and their greater reliance on development assistance hinder investments in public health to adequately prevent risk factors for NCDs or manage established disease. Public private partnerships (PPP) can deliver smart health solutions to improve the health outcomes of those at risk of NCDs and those who have an illness. These solutions can range from simple digital concepts to complex technology constructs that can utilize artificial intelligence to intervene at many touch points along the patient journey. We present three case studies of smart health deployed through PPP to try improving outcomes.
主要的非传染性疾病，如心血管疾病、糖尿病、癌症和慢性呼吸道疾病，占全球所有死亡人数的71%。其中许多死亡是过早死亡，对低收入和中等收入国家影响最大。低收入和中等收入国家的经济现实以及它们对发展援助的更大依赖，阻碍了对公共卫生的投资，无法充分预防非传染性疾病的风险因素或管理已确诊的疾病。公私伙伴关系可以提供智能健康解决方案，以改善面临非传染性疾病风险的人群和患病者的健康状况。这些解决方案可以从简单的数字概念到复杂的技术架构，利用人工智能在患者就医过程中的多个接触点进行干预。我们介绍了通过公私伙伴关系部署的三个智能健康案例研究，以尝试改善结果。
